BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Nightstar Expands Pipeline With Novel Gene Therapy for the Treatment of Stargardt Disease

  Stargardt disease is the most common form of inherited juvenile macular dystrophy with a prevalence of one in 10,000.

  November 8, 2017

   · 

  5 min read
• Arocell AB: Abstract Published Presenting Arocell TK 210 ELISA From the PROMIX Study at the European Society for Medical Oncology Congress in Singapore, November 17-19, 2017

  The investigators quantified cell loss using the AroCell TK 210 ELISA kit to measure serum TK1 in serial samples from 145 breast cancer patients undergoing chemotherapy before surgery.

  November 8, 2017

   · 

  2 min read
• Business

  REPROCELL Chooses Science Exchange as the Preferred Partner to Increase Accessibility of its Predictive Drug Discovery Services

  Science Exchange announced today that ReproCELL has selected the Science Exchange platform as the primary marketplace to offer access to its predictive drug discovery assays for the biopharma research community.

  November 8, 2017

   · 

  3 min read
• Business

  Lundbeck Increased Operating Profit (EBIT) With 126% and EPS by 182% in the First Nine Months of 2017

  Revenue reached DKK 12,842 million in the first nine months of 2017 representing an increase of 12% (13% in local currencies) compared to the same period last year.

  November 8, 2017

   · 

  2 min read
• Business

  ThromboGenics Strengthens Leadership Team - Susan Schneider, MD Appointed Chief Medical Officer and Vinciane Vangeersdaele Appointed Chief Commercial Officer

  Both will be members of the Company’s executive team reporting to ThromboGenics’ CEO, and they will operate from the Company’s offices in Leuven, Belgium and Iselin, New Jersey, US.

  November 8, 2017

   · 

  4 min read
• Business

  Protalix BioTherapeutics Reports 2017 Third Quarter Results and Provides Corporate Update

  The Company reported a net loss of $32.1 million, or $0.25 per share, basic and diluted, for the nine-month period ended September 30, 2017.

  November 8, 2017

   · 

  11 min read
• Business

  Photocure ASA: Results for the Third Quarter of 2017

  Photocure reported total group revenues of NOK 35.6 million in the third quarter of 2017 (35.2).

  November 8, 2017

   · 

  4 min read
• University of Saskatchewan-NRGene Crop Research Partnership Maps Two Lentil Genomes

  In cutting-edge research aimed at breeding better lentils, a partnership between University of Saskatchewan crop scientists and world-leading genomic big data company NRGene of Israel has successfully sequenced two wild lentil genomes-the largest legume genomes ever assembled.

  November 8, 2017

   · 

  3 min read
• Genetown

  Voyager Therapeutics Announces Pricing of Public Offering of Common Stock

  Voyager has granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of common stock at the public offering price.

  November 8, 2017

   · 

  4 min read
• BioMidwest

  Sun BioPharma Announces Execution of Reverse Stock Split

  The reverse stock split will be effective as of the close of business on November 7, 2017.

  November 8, 2017

   · 

  5 min read